Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Markets

Pharmacy Facelift: How Walgreens and CVS Aim to Boost Profits

by Team Lumida
May 17, 2024
in Markets, News
Reading Time: 4 mins read
A A
0
woman with face mask holding an alcohol bottle

Photo by Anna Tarazevich on Pexels.com

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways

  1. Walgreens and CVS are redesigning stores to emphasize health and wellness.
  2. Rising competition and falling margins drive these changes.
  3. Investors should watch for potential improvements in profitability and customer satisfaction.

What Happened?

Walgreens and CVS are drastically revamping their store layouts to focus on health and wellness, aiming to counter sagging performance. Walgreens, for example, is testing a new store design in Aubrey, Texas, where the pharmacy counter is moved to the front, and customers use self-service kiosks.

CVS is integrating its Oak Street Health primary-care centers into some stores. Both chains have seen significant declines in operating margins, with Walgreens’ U.S. pharmacy operating margin dropping to -5% last year. These redesign efforts are part of broader strategies to improve efficiency and customer experience amid fierce competition from Amazon, Dollar General, and Walmart.

Why It Matters?

These changes are crucial as both Walgreens and CVS struggle with falling margins and investor dissatisfaction. Walgreens’ shares have plummeted 77% over the past decade, and CVS’ shares have dropped 26%.

By making pharmacies more customer-friendly and efficient, they aim to attract more customers and boost profitability. These efforts are essential for long-term sustainability, especially given the increasing role of pharmacists in healthcare services, such as vaccinations and testing.

What’s Next?

Investors should monitor the success of these pilot stores and any subsequent rollouts. If these new designs prove effective, we could see a broader implementation, potentially improving the financial outlook for both companies.

Additionally, keep an eye on the labor situation; reducing pharmacists’ workloads could enhance service quality and customer satisfaction. The success of these initiatives could also pressure competitors to innovate, potentially reshaping the entire pharmacy landscape.

Source: Bloomberg
Previous Post

Medicare Shakeup: Policy Changes Rattle Big Insurers

Next Post

Revolutionizing AI: How DePIN is Solving Robots’ Biggest Blind Spot

Recommended For You

D.R. Horton Misses by 35 Cents and Forecasts About 5,000 Fewer Home Closings Next Year, Saying Expecting Rate Cuts Would Be ‘Imprudent’

by Team Lumida
5 hours ago

D.R. Horton earned $2.67 a share vs. $3.02 expected and sees as few as 79,000 closings in fiscal 2027, down from about 84,000, with incentives staying high.

Read more

Mastercard Beats by 14 Cents as Revenue Jumps 14% to $9.81 Billion and Its Fraud and Data Services Arm Grows 19%

by Team Lumida
5 hours ago
person holding debit card

Mastercard earned an adjusted $5.31 a share vs. $5.17 expected on 14% revenue growth to $9.81 billion, lifted by payments volume and services.

Read more

US Federal Debt Hits 100% of GDP for the First Time Since 1946, About 6 Points Shy of the World War II Record, as the Deficit Runs at 6.2%

by Team Lumida
5 hours ago
Private Debt Surges Past Private Equity: Key Insights

Debt held by the public reached $32.2 trillion, or 100.03% of GDP, at the end of fiscal 2026, the highest ratio since 1946, as the deficit neared $2...

Read more

Josh Kushner’s Thrive Holdings Will Buy ADT for $7.6 Billion in Cash at a 35% Premium, Betting AI Can Remake the Home-Security Giant

by Team Lumida
5 hours ago

Thrive Holdings will pay $10 a share in cash for ADT, a 35% premium, in a deal valued at $15.3 billion including debt and backed by Apollo financing.

Read more

Microsoft Seeks at Least $25 Billion in Its First US Bond Sale Since 2017, a Test of AI Debt Appetite as Its Rare AAA Paper Prices Near Alphabet and Amazon

by Team Lumida
5 hours ago

Microsoft is marketing at least $25 billion of AAA-rated bonds in up to 10 tranches, its first US high-grade sale since 2017, as AI borrowing hits records.

Read more

A Canton Network Venue Could Beat OKX-ICE to the First Tokenized Stock Trade Under the SEC’s New Framework as Soon as Monday

by Team Lumida
5 hours ago

Canton Strategic Holdings plans to list tokenized shares on TSV LLC as soon as Nov. 2, sidestepping the issuer objections that hit OKX-ICE.

Read more

Oil Drops as Much as 2.8%, Pushing WTI Below $100, After Vance Reportedly Reaches Out to Iran, but Post-Midterm Strike Fears Keep Brent Near $113

by Team Lumida
5 hours ago

Brent fell 2% to $112.99 and WTI 2.8% to $99.91 after reports of US outreach to Iran, though fears of action after the Nov. 3 midterms linger.

Read more

US Home Prices Fall and Rents Rise for the First Time in Over Three Years, as Pending Sales Sink to a 25-Year Low

by Team Lumida
5 hours ago

Redfin says the median US home price fell 0.1% from a year earlier, while Apartment List says rents rose 0.1%, both firsts in more than three years.

Read more

Kalshi Nearly Doubles Its Valuation to $40 Billion in Five Months, as Polymarket Rolls Out Five-Minute Bitcoin Bets for US Traders

by Team Lumida
5 hours ago

Kalshi raised $1 billion at a $40 billion valuation, up from $22 billion in May, as Polymarket launched five-minute crypto contracts on its US platform.

Read more

NYSE Owner ICE Moves to Bring Hyperliquid-Style Perpetual Futures on Stocks and Crypto to the US, With Druckenmiller Among the Backers

by Team Lumida
5 hours ago

ICE and Trade plan ICE, a US venue for 24/7 perpetual futures on stocks, commodities, FX and crypto, pending CFTC approval.

Read more
Next Post

Revolutionizing AI: How DePIN is Solving Robots’ Biggest Blind Spot

NFT Nightmare: Dolce & Gabbana Sued Over NFT Misstep

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Why Iran Thinks It Won the War — Despite Catastrophic Military Losses

Iran Chases Economic Relief — Without Letting Trump Claim Victory

May 27, 2026
a group of rings

U.S. Plans National Bitcoin Reserve, Sparking Global Crypto Race

February 17, 2025
A store filled with lots of different types of clothing

Economic Shifts: U.S. and China Consumers Tighten Their Wallets

August 5, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bank of America China Commercial Real Estate CPI data centers Donald Trump EARNINGS ELON MUSK Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Novo Nordisk Nuclear Energy Nvidia oil OpenAI private equity S&P 500 SEC Semiconductor stock market stock surge Tech Stocks tesla Trump Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018